- Home
- RLGT vs ATYR Comparison
RLGT vs ATYR Comparison
Compare RLGT & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- ATYR
- Stock Information
- Founded
- RLGT 2001
- ATYR 2005
- Country
- RLGT United States
- ATYR United States
- Employees
- RLGT N/A
- ATYR N/A
- Industry
- RLGT Oil Refining/Marketing
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RLGT Consumer Discretionary
- ATYR Health Care
- Exchange
- RLGT Nasdaq
- ATYR Nasdaq
- Market Cap
- RLGT 295.7M
- ATYR 327.0M
- IPO Year
- RLGT N/A
- ATYR 2015
- Fundamental
- Price
- RLGT $6.22
- ATYR $2.88
- Analyst Decision
- RLGT
- ATYR Strong Buy
- Analyst Count
- RLGT 0
- ATYR 6
- Target Price
- RLGT N/A
- ATYR $18.60
- AVG Volume (30 Days)
- RLGT 167.5K
- ATYR 1.6M
- Earning Date
- RLGT 05-08-2025
- ATYR 03-13-2025
- Dividend Yield
- RLGT N/A
- ATYR N/A
- EPS Growth
- RLGT 32.26
- ATYR N/A
- EPS
- RLGT 0.29
- ATYR N/A
- Revenue
- RLGT $858,699,000.00
- ATYR $235,000.00
- Revenue This Year
- RLGT $12.86
- ATYR $1,387.23
- Revenue Next Year
- RLGT $5.75
- ATYR $873.22
- P/E Ratio
- RLGT $21.19
- ATYR N/A
- Revenue Growth
- RLGT N/A
- ATYR N/A
- 52 Week Low
- RLGT $4.83
- ATYR $1.42
- 52 Week High
- RLGT $7.94
- ATYR $4.66
- Technical
- Relative Strength Index (RSI)
- RLGT 41.00
- ATYR 34.46
- Support Level
- RLGT $6.04
- ATYR $3.20
- Resistance Level
- RLGT $6.35
- ATYR $3.94
- Average True Range (ATR)
- RLGT 0.16
- ATYR 0.28
- MACD
- RLGT 0.01
- ATYR -0.08
- Stochastic Oscillator
- RLGT 36.46
- ATYR 0.00
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.